HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas C Quinn Selected Research

Trachoma

1/2022Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania.
1/2020The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children.
12/2019Evidence for contamination with C. trachomatis in the household environment of children with active Trachoma: A cross-sectional study in Kongwa, Tanzania.
1/2018Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area.
1/2016Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey.
7/2014Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
6/2014Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment.
4/2014Cohort and age effects of mass drug administration on prevalence of trachoma: a longitudinal study in rural Tanzania.
4/2014The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.
1/2013Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas C Quinn Research Topics

Disease

68Infections
03/2024 - 02/2002
31HIV Infections (HIV Infection)
04/2024 - 08/2002
23COVID-19
09/2023 - 09/2020
15Trachoma
01/2022 - 04/2009
11Disease Progression
01/2019 - 03/2008
10Sexually Transmitted Diseases (Sexually Transmitted Disease)
10/2020 - 02/2002
9Viremia
06/2023 - 04/2002
8Ulcer
01/2023 - 11/2009
8Superinfection
01/2019 - 07/2012
7Acquired Immunodeficiency Syndrome (AIDS)
01/2018 - 04/2002
7Measles
10/2009 - 04/2002
6Syphilis
12/2022 - 01/2005
6Papillomavirus Infections
01/2021 - 03/2009
5Inflammation (Inflammations)
01/2022 - 05/2016
5Herpes Genitalis (Genital Herpes)
08/2015 - 06/2005
4Coinfection
01/2015 - 04/2002
3Persistent Infection
03/2024 - 05/2011
3Liver Diseases (Liver Disease)
07/2013 - 01/2011
2Chronic Disease (Chronic Diseases)
05/2022 - 01/2022
2Cough
02/2022 - 01/2022
2Pharyngitis (Sore Throat)
02/2022 - 01/2022
2Cognitive Dysfunction
01/2021 - 09/2009
2Herpes Simplex
03/2016 - 11/2015
2Malaria
02/2016 - 01/2010
2Chlamydia Infections
12/2015 - 07/2003
2Wounds and Injuries (Trauma)
11/2015 - 04/2015
2Blindness (Hysterical Blindness)
03/2011 - 04/2009
2Opportunistic Infections (Opportunistic Infection)
04/2010 - 11/2002
2Retinitis
10/2002 - 04/2002
2Cytomegalovirus Retinitis
10/2002 - 04/2002
1Meningoencephalitis
01/2022
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020
1Neoplasms (Cancer)
01/2020
1Neurocognitive Disorders (Clerambault Syndrome)
01/2020
1Eye Infections
12/2019

Drug/Important Bio-Agent (IBA)

21AntibodiesIBA
11/2022 - 12/2007
19RNA (Ribonucleic Acid)IBA
10/2021 - 04/2002
15Immunoglobulin G (IgG)IBA
09/2023 - 03/2002
12Azithromycin (Zithromax)FDA LinkGeneric
12/2019 - 01/2005
9VaccinesIBA
09/2023 - 10/2006
8EpitopesIBA
05/2022 - 10/2020
8Neutralizing AntibodiesIBA
01/2022 - 01/2017
8DNA (Deoxyribonucleic Acid)IBA
01/2020 - 02/2002
6Nucleic AcidsIBA
01/2019 - 02/2002
6AntigensIBA
01/2018 - 04/2009
5Immunoglobulin M (IgM)IBA
11/2022 - 02/2008
5Peptides (Polypeptides)IBA
01/2022 - 10/2020
5Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 01/2013
5EnzymesIBA
04/2014 - 10/2002
4CytokinesIBA
02/2021 - 04/2009
4Antiviral Agents (Antivirals)IBA
01/2021 - 11/2002
4Interleukin-6 (Interleukin 6)IBA
10/2019 - 04/2011
4Lipopolysaccharide ReceptorsIBA
11/2015 - 04/2009
4Measles VaccineIBA
10/2009 - 08/2007
3Immunoglobulin A (IgA)IBA
11/2022 - 01/2019
3Amino AcidsFDA Link
01/2022 - 01/2014
3N 30IBA
12/2021 - 02/2021
3Biomarkers (Surrogate Marker)IBA
07/2021 - 05/2016
3Acyclovir (Aciclovir)FDA LinkGeneric
01/2017 - 06/2012
3insulin receptor-related receptor (IRR)IBA
03/2014 - 11/2009
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2022 - 12/2021
2Monoclonal AntibodiesIBA
01/2021 - 04/2002
2Interleukin-2 (IL2)IBA
03/2016 - 07/2013
2Antimalarials (Antimalarial Agents)IBA
02/2016 - 01/2010
2Glycoproteins (Glycoprotein)IBA
08/2015 - 12/2007
2AIDS VaccinesIBA
03/2014 - 07/2012
2Complement System Proteins (Complement)IBA
12/2011 - 04/2009
2ImmunosorbentsIBA
05/2008 - 12/2007
2Ligases (Synthetase)IBA
02/2002 - 02/2002
1COVID-19 VaccinesIBA
01/2023
1ReaginsIBA
12/2022
1Immunoglobulins (Immunoglobulin)IBA
11/2022
1Heparin (Liquaemin)FDA LinkGeneric
11/2022
1Immunoglobulin IsotypesIBA
11/2022
1Platelet Factor 4IBA
11/2022
1Lactic Acid (Lactate)FDA LinkGeneric
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1ABO Blood-Group SystemIBA
08/2021
1Blood Group Antigens (Blood Groups)IBA
08/2021
1ChemokinesIBA
02/2021
1Antigen-Antibody Complex (Immune Complex)IBA
01/2021
1GlobulinsIBA
01/2021
1ProteomeIBA
10/2020
1Illicit Drugs (Recreational Drugs)IBA
10/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020
1Enfuvirtide (Fuzeon)FDA Link
01/2020
1Broadly Neutralizing AntibodiesIBA
01/2018
1Fatty Acid-Binding ProteinsIBA
05/2016
1Indicators and Reagents (Reagents)IBA
01/2016

Therapy/Procedure

25Therapeutics
04/2024 - 04/2002
20Male Circumcision
11/2017 - 02/2007
12Art Therapy
06/2023 - 01/2011
8Mass Drug Administration
01/2020 - 07/2011
7Condoms (Condom)
06/2023 - 07/2003
6Highly Active Antiretroviral Therapy (HAART)
02/2005 - 09/2002
2Continuity of Patient Care
07/2015 - 01/2015
1Organ Transplantation
10/2022
1Hand Hygiene
02/2022
1Transplantation
01/2020
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2020